✅ Innovation in grant acquisition by developing groundbreaking technology.
✅ Microbiome's critical role in human health and disease prevention.
✅ Revolutionary approach to microbiome mining with large-scale technology.
In this episode of "Failing to Success," we welcome Ross Youngs, founder of Biosortia, to discuss the innovative process of raising grants and the transformative technology in microbiome mining. Ross reveals how Biosortia has secured around $9 million in grants and over $22 million in total capital. He explains the critical role of the microbiome in human health, noting that we have more microbial cells than human cells. Biosortia's groundbreaking technology enables large-scale extraction and analysis of untapped microbes, paving the way for significant advancements in therapeutics, agriculture, and more. This technology could revolutionize our understanding and application of microbiome science.
00:00 Introduction to Ross Youngs and Biosortia
00:16 The Financial Journey: Grants and Capital Raised
00:56 Exploring the Microbiome: Untapped Microbes and Technology
03:34 The Revolutionary Approach to Microbiome Mining
04:59 The Impact of Microbiome on Human Health and Beyond
05:57 Scaling Up: The Future of Microbiome Mining
08:16 Closing Remarks and How to Learn More
Around $9 million.
Over $22 million, including angel investors and grants.
By developing innovative technology that catches the attention of granting agencies looking to support next-generation technologies.
It's the process of extracting and analyzing microbes at a large scale and quality to discover untapped molecules and enzymes that have vast potential applications.
Microbes outnumber human cells and genes, playing a crucial role in disease courses, inflammation, and overall health, making them vital for therapeutic opportunities.
